BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 12669348)

  • 1. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
    Famin O; Ginsburg H
    Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin-Ferriprotoporphyrin IX Adduct Abundance in Plasmodium falciparum Malarial Parasites and the Relationship to Emerging Artemisinin Resistance.
    Heller LE; Goggins E; Roepe PD
    Biochemistry; 2018 Dec; 57(51):6935-6945. PubMed ID: 30512926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs.
    Famin O; Krugliak M; Ginsburg H
    Biochem Pharmacol; 1999 Jul; 58(1):59-68. PubMed ID: 10403519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum.
    Bray PG; Janneh O; Raynes KJ; Mungthin M; Ginsburg H; Ward SA
    J Cell Biol; 1999 Apr; 145(2):363-76. PubMed ID: 10209030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.
    Famin O; Ginsburg H
    Biochem Pharmacol; 2002 Feb; 63(3):393-8. PubMed ID: 11853690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine mediates specific proteome oxidative damage across the erythrocytic cycle of resistant Plasmodium falciparum.
    Radfar A; Diez A; Bautista JM
    Free Radic Biol Med; 2008 Jun; 44(12):2034-42. PubMed ID: 18397762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S; Walter RD; Müller S
    Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysis of malarial parasites and erythrocytes by ferriprotoporphyrin IX-chloroquine and the inhibition of this effect by proteins.
    Zhang Y; Hempelmann E
    Biochem Pharmacol; 1987 Apr; 36(8):1267-73. PubMed ID: 3297071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine - some open questions on its antimalarial mode of action and resistance.
    Ginsburg H; Krugliak M
    Drug Resist Updat; 1999 Jun; 2(3):180-187. PubMed ID: 11504489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance Transporter.
    Richards SN; Nash MN; Baker ES; Webster MW; Lehane AM; Shafik SH; Martin RE
    PLoS Pathog; 2016 Jul; 12(7):e1005725. PubMed ID: 27441371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of Free Ferriprotoporphyrin IX Heme and Hemozoin for Artemisinin Sensitive versus Delayed Clearance Phenotype Plasmodium falciparum Malarial Parasites.
    Heller LE; Roepe PD
    Biochemistry; 2018 Dec; 57(51):6927-6934. PubMed ID: 30513202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs.
    Zhang J; Krugliak M; Ginsburg H
    Mol Biochem Parasitol; 1999 Mar; 99(1):129-41. PubMed ID: 10215030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme binding contributes to antimalarial activity of bis-quaternary ammoniums.
    Biagini GA; Richier E; Bray PG; Calas M; Vial H; Ward SA
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2584-9. PubMed ID: 12878523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of antimalarial drugs.
    Fitch CD
    Ciba Found Symp; 1983; 94():222-32. PubMed ID: 6341003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characteristics of the malaria parasite's "chloroquine resistance transporter": implications for chemotherapy.
    Summers RL; Martin RE
    Virulence; 2010; 1(4):304-8. PubMed ID: 21178460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diamidine compounds: selective uptake and targeting in Plasmodium falciparum.
    Stead AM; Bray PG; Edwards IG; DeKoning HP; Elford BC; Stocks PA; Ward SA
    Mol Pharmacol; 2001 May; 59(5):1298-306. PubMed ID: 11306715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium.
    Ginsburg H; Golenser J
    Redox Rep; 2003; 8(5):276-9. PubMed ID: 14962364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
    Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
    Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of malaria parasite growth by quinomycin A and its derivatives through DNA-intercalating activity.
    Hayase H; Watanabe N; Lim CL; Nogawa T; Komatsuya K; Kita K; Osada H
    Biosci Biotechnol Biochem; 2015; 79(4):633-5. PubMed ID: 25471083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.